Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ELDNELDN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ELEDON PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 2.5M shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $9.9M as of 2026-Q2. The position was increased (+578.3% shares). ELDN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$9.9M

Current Shares

2.5M

Total Value Change

+$9.3M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+578.3%
$9.9M0.0%$3.94
45
2026-Q1
Increased
370,090
+86.2%
$1.1M0.0%$2.50
39
2025-Q4
Increased
198,712
+225.7%
$300,0550.0%$1.51
26
2025-Q3
Increased
61,006
+127.0%
$158,0050.0%$2.54
25
2025-Q2
Decreased
26,871
-89.6%
$72,8200.0%$2.69
0
2025-Q1
Increased
258,106
+78.2%
$874,9790.0%$3.35
38
2024-Q4
New
144,845
-
$596,7610.0%$4.14
34

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used